Levo Therapeutics
Joseph Mancini is an accomplished professional in the field of biochemistry, holding a PhD from McGill University. Currently serving as Vice President of Research and Innovation at adMare BioInnovations and as a Scientific Advisor at Levo Therapeutics, Joseph has built a distinguished career that includes significant leadership roles at Vertex Pharmaceuticals and Otsuka Canada Pharmaceutical Inc. Additionally, Joseph contributes to academia as an Adjunct Professor at McGill University. With extensive expertise in drug discovery and management, Joseph has successfully led numerous projects and teams, particularly in the areas of diabetes and obesity during tenure at Merck.
This person is not in any teams
This person is not in any offices
Levo Therapeutics
Levo Therapeutics is a biomedical research and development services intended to treat the multisystem neurodevelopmental disorder. The company's research and development services are dedicated to using genetic insights to advance treatments for Prader-Willi syndrome and related disorders, enabling patients to get cured of severeneurodevelopmental disorders.